Literature DB >> 12439834

Comorbidity of substance abuse and other psychiatric disorders in acute general psychiatric admissions: a study from Lebanon.

Elie G Karam1, Philippe F Yabroudi, Nadine M Melhem.   

Abstract

This is the first published study from an Arab Near Eastern country to examine the comorbidity of substance abuse with other psychiatric disorders. All inpatients with substance abuse/dependence (present or past) admitted to the psychiatry unit at St. George Hospital (Lebanon) between 1979 and 1992 (N = 222) constituted the study sample. Of these, 64.9% were found to have comorbid psychiatric disorders with specific relations between individual substances and psychiatric diagnoses identified such as cocaine and bipolar disorder (42.1%), and cannabis and schizophrenia (44.8%). Patients with no axis I disorder were predominantly heroin users, most of them having antisocial personality disorder. Polydrug abuse was found among 44.9% of patients, and most of the benzodiazepine abusers belonged to this category. The pattern of comorbidity of psychiatric and substance use disorders in this Near East inpatient population compares well with findings from the Western hemisphere: cultural factors (including war) do not seem to have much of an effect on the different forms of dual diagnoses. This adds weight to the already existing literature on the need for careful psychiatric assessment in the treatment of substance abuse. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Year:  2002        PMID: 12439834     DOI: 10.1053/comp.2002.35910

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  8 in total

1.  Enemy within?: The silent epidemic of substance dependency in GCC countries.

Authors:  Abdullah Al-Harthi; Samir Al-Adawi
Journal:  J Sci Res Med Sci       Date:  2002-04

Review 2.  The link between schizophrenia and substance use disorder: A unifying hypothesis.

Authors:  Jibran Y Khokhar; Lucas L Dwiel; Angela M Henricks; Wilder T Doucette; Alan I Green
Journal:  Schizophr Res       Date:  2017-04-14       Impact factor: 4.939

3.  Impact of opium dependency on clinical and neuropsychological indices of multiple sclerosis patients.

Authors:  Fatemeh Ayoobi; Reza Bidaki; Ali Shamsizadeh; Amir Moghadam-Ahmadi; Houshang Amiri
Journal:  Neurol Sci       Date:  2019-07-01       Impact factor: 3.307

4.  Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis.

Authors:  Johanna Koskinen; Johanna Löhönen; Hannu Koponen; Matti Isohanni; Jouko Miettunen
Journal:  Schizophr Bull       Date:  2009-04-22       Impact factor: 9.306

5.  Rapid assessment response (RAR) study: drug use and health risk - Pretoria, South Africa.

Authors:  Monika Ml Dos Santos; Franz Trautmann; John-Peter Kools
Journal:  Harm Reduct J       Date:  2011-06-01

6.  Challenges in detecting and diagnosing substance use in women in the acute psychiatric department: a naturalistic cohort study.

Authors:  Torill Vassli Sallaup; Arne Einar Vaaler; Valentina Cabral Iversen; Ismail Cuneyt Guzey
Journal:  BMC Psychiatry       Date:  2016-11-17       Impact factor: 3.630

7.  A systematic review and meta-analysis of sex differences in cannabis use disorder amongst people with comorbid mental illness.

Authors:  Karolina Kozak; Philip H Smith; Darby J E Lowe; Andrea H Weinberger; Ziva D Cooper; Rachel A Rabin; Tony P George
Journal:  Am J Drug Alcohol Abuse       Date:  2021-07-19       Impact factor: 3.912

8.  Comparative Evaluation of Psychiatric Disorders in Opium and Heroin Dependent Patients†This article has been published in the Journal of Rafsanjan University of Medical Sciences in Persian language.

Authors:  Alireza Ghaffari Nejad; Hassan Ziaadini; Nabi Banazadeh
Journal:  Addict Health       Date:  2009
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.